Translating Biomedical Innovations into Health-System Adoption in Low-Resource Settings: Challenges, Determinants, and Sustainability

Abstract

Biomedical innovations may demonstrate strong technical performance without achieving sustained clinical or population health benefit in low-resource settings. This review critically examines how innovations progress from discovery to health-system adoption, identifies points at which translational value may be lost, and proposes an integrated interpretation of determinants of sustained impact. A critical narrative review synthesized evidence from biomedical, diagnostic, health-system and implementation research, with emphasis on technical performance, clinical utility, contextual fit, health-system capability, regulation, procurement, implementation, sustainability, scale and equity. Diagnostics were used as the principal empirical exemplar. Evidence indicates that technical validity is necessary but insufficient for clinical value. Implementation depends on interacting influences involving workflow, workforce, infrastructure, financing, supply systems, policy and organizational context. Regulation and procurement affect safe introduction and life-cycle viability, while adoption, sustainability, scale and equity are distinct outcomes rather than interchangeable markers of success. Three author-derived  analytical failure modes were identified: innovation failure, translation/system failure, and contextual-fit failure. Translational loss frequently occurs at interfaces between technology, clinical decision-making, service delivery and population access. Biomedical translation in low-resource settings should therefore be understood as an iterative process in which technological, clinical, organisational and contextual value must be demonstrated repeatedly. Longitudinal, multidisciplinary evaluation is needed to establish how innovations can achieve sustained and equitable health-system impact